I am a
Home I AM A Search Login

Papers of the Week

Papers: 8 Oct 2022 - 14 Oct 2022


2022 Oct 12

JAMA Dermatol

Measuring Atopic Eczema Control and Itch Intensity in Clinical Practice: A Consensus Statement From the Harmonising Outcome Measures for Eczema in Clinical Practice (HOME-CP) Initiative.


Leshem YA, Chalmers JR, Apfelbacher C, Katoh N, Gerbens L A, Schmitt J, Spuls PI, Thomas KS, Howells L, Williams HC, L Simpson E
JAMA Dermatol. 2022 Oct 12.
PMID: 36223090.


Measuring outcomes in clinical practice can aid patient care, quality improvement, and real-world evidence generation. The Harmonising Outcome Measures for Eczema (HOME) Clinical Practice initiative is developing a list of validated, feasible instruments to measure atopic eczema in clinical care. Prior work identified symptoms and long-term control as the most important domains to measure in clinical practice. The Patient-Oriented Eczema Measure (POEM) and the Patient-Oriented Scoring Atopic Dermatitis Index (PO-SCORAD) were recommended by consensus to measure symptoms in clinical practice, but a need for instruments to measure itch intensity specifically was recognized. The HOME group also previously decided that long-term control should be captured by repeated measurements of eczema control. Recommended instruments to measure eczema control in clinical practice have not been defined.